 |
|
Very Late-Onset Friedreich Ataxia Despite Large GAA Triplet Repeat Expansions
Sanjay I. Bidichandani, MBBS, PhD;
Carlos A. Garcia, MD;
Pragna I. Patel, PhD;
Mazen M. Dimachkie, MD
Arch Neurol. 2000;57:246-251.
Background Most patients with Friedreich ataxia (FRDA) have abnormal GAA triplet repeat expansions in both X25 genes. The size of the GAA expansion in the shorter of the 2 expanded alleles correlates significantly with parameters of clinical severity and is inversely related to the age at onset.
Objectives To describe the clinical and molecular genetic findings in a patient with very late-onset FRDA and to review the literature.
Patient and Methods A 58-year-old white woman with mild progressive gait disturbance of 15 years' duration whose examination revealed mild incoordination was analyzed for mutations in the X25 gene. A combination of long-range polymerase chain reaction and genomic Southern blot analyses were used to identify GAA expansions in intron 1 of the X25 gene. To uncover evidence of somatic variability in triplet repeat length, DNA isolated from several tissue samples was similarly analyzed. Single-strand conformational polymorphism analysis was used to screen for mutations spanning the entire coding sequence of frataxin and all intron-exon junctions of the X25 gene.
Results DNA isolated from blood leukocytes revealed GAA triplet repeat expansions in both X25 genes, which were estimated to contain 835 and 1200 repeats. Similar expansions were detected in DNA isolated from lymphoblasts, fibroblasts, buccal cells, and sural nerve, with estimated mean (±SD) lengths of the shorter and longer expansions being 854 (±69) and 1283 (±72) triplets, respectively. A review of reported cases of late-onset Friedreich ataxia (25-39 years) and very late-onset Friedreich ataxia ( 40 years) demonstrated that this is the first instance of a patient presenting with very late-onset FRDA despite carrying more than 800 GAA repeats in both expanded X25 alleles.
Conclusions This unique case of very late-onset FRDA highlights a limitation in our ability to accurately predict the phenotype in FRDA based solely on the size of the GAA expansion. Other genetic or environmental factors may significantly modify disease severity in FRDA.
From the Departments of Neurology (Drs Bidichandani and Patel) and Molecular and Human Genetics (Dr Patel) and Division of Neuroscience (Dr Patel), Baylor College of Medicine, Houston, Tex; Department of Psychiatry and Neurology (Dr Garcia), Tulane University, New Orleans, La; and Department of Neurology (Dr Dimachkie), The University of Texas–Houston Medical School.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(2):284-285.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The GAA triplet-repeat sequence in Friedreich ataxia shows a high level of somatic instability in vivo, with a significant predilection for large contractions
Sharma et al.
Hum Mol Genet 2002;11:2175-2187.
ABSTRACT
| FULL TEXT
Friedreich Ataxia: Effects of Genetic Understanding on Clinical Evaluation and Therapy
Lynch et al.
Arch Neurol 2002;59:743-747.
ABSTRACT
| FULL TEXT
Very late onset Friedreich's presenting as spastic tetraparesis without ataxia or neuropathy
Lhatoo et al.
Neurology 2001;56:1776-1777.
FULL TEXT
Atypical Friedreich Ataxia With a Very Late Onset and an Unusual Limited GAA Repeat
Sorbi et al.
Arch Neurol 2000;57:1380-1382.
FULL TEXT
|
